228 related articles for article (PubMed ID: 32548641)
21. Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.
Mesquita J; Cavaco D; Ferreira AM; Costa FM; Carmo P; Morgado F; Mendes M; Adragão P
J Interv Card Electrophysiol; 2018 Jun; 52(1):39-45. PubMed ID: 29511973
[TBL] [Abstract][Full Text] [Related]
22. Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure.
Mesquita J; Ferreira AM; Cavaco D; Carmo P; Madeira M; Freitas P; Costa FM; Morgado F; Mendes M; Adragão P
Int J Cardiol; 2018 May; 259():82-87. PubMed ID: 29579616
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome after catheter ablation of paroxysmal atrial fibrillation: Impact of different atrial fibrillation foci.
Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Nakashima E; Nakajima J; Yamao K; Takagi K; Tanaka Y; Fujino T; Kimura S; Hikita H; Hirao K; Isobe M
Int J Cardiol; 2017 Jan; 227():407-412. PubMed ID: 27838128
[TBL] [Abstract][Full Text] [Related]
24. Effect of Combined Pulmonary Vein and Superior Vena Cava Isolation on the Outcome of Second Catheter Ablation for Paroxysmal Atrial Fibrillation.
Zhang T; Wang Y; Liang Z; Zhao H; Han Z; Wang Y; Wu Y; Ren X
Am J Cardiol; 2020 Jun; 125(12):1845-1850. PubMed ID: 32305224
[TBL] [Abstract][Full Text] [Related]
25. 10-Year Outcomes of Patients With Non-Paroxysmal Atrial Fibrillation Undergoing Catheter Ablation.
Tsai TY; Lo LW; Cheng WH; Liu SH; Lin YJ; Chang SL; Hu YF; Chung FP; Liao JN; Tuan TC; Chao TF; Lin CY; Chang TY; Liu CM; Chheng C; Hermanto DY; An TN; Elimam AMM; Huang TC; Lee PT; Lee CH; Chen SA
Circ J; 2022 Dec; 87(1):84-91. PubMed ID: 36130901
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of the nonpulmonary vein foci induced after second-generation cryoballoon ablation for paroxysmal atrial fibrillation.
Kato N; Nitta J; Sato A; Inamura Y; Takamiya T; Inaba O; Negi K; Takahashi Y; Goya M; Sasano T
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):174-184. PubMed ID: 31828893
[TBL] [Abstract][Full Text] [Related]
27. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.
Boersma L; Koźluk E; Maglia G; de Sousa J; Grebe O; Eckardt L; Hokanson RB; Hemingway LA; Ostern E; Park HS; Rovaris G; Arribas F; Scharf C; Csanádi Z; Arenal Á; Laurenzi F; Klaver M; Goette A
Europace; 2020 Jun; 22(6):888-896. PubMed ID: 32219388
[TBL] [Abstract][Full Text] [Related]
28. Long duration of radiofrequency energy delivery is an independent predictor of clinical recurrence after catheter ablation of atrial fibrillation: over 500 cases experience.
Shim J; Joung B; Park JH; Uhm JS; Lee MH; Pak HN
Int J Cardiol; 2013 Sep; 167(6):2667-72. PubMed ID: 22790188
[TBL] [Abstract][Full Text] [Related]
29. Outcomes after cryoablation vs. radiofrequency in patients with paroxysmal atrial fibrillation: impact of pulmonary veins anatomy.
Khoueiry Z; Albenque JP; Providencia R; Combes S; Combes N; Jourda F; Sousa PA; Cardin C; Pasquie JL; Cung TT; Massin F; Marijon E; Boveda S
Europace; 2016 Sep; 18(9):1343-51. PubMed ID: 26817755
[TBL] [Abstract][Full Text] [Related]
30. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
[TBL] [Abstract][Full Text] [Related]
31. Serum relaxin level predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
Qu X; Chen L; Sun L; Chen C; Gao Z; Huang W; Zhou H
Heart Vessels; 2019 Sep; 34(9):1543-1551. PubMed ID: 30937522
[TBL] [Abstract][Full Text] [Related]
32. History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation.
Wongcharoen W; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Chong E; Chao TF; Tuan TC; Chang YT; Lin CY; Liao JN; Lin YC; Chen YY; Chen SA
Heart Rhythm; 2015 Sep; 12(9):1956-62. PubMed ID: 26049050
[TBL] [Abstract][Full Text] [Related]
33. Arrhythmia recurrence is more common in females undergoing multiple catheter ablation procedures for persistent atrial fibrillation: Time to close the gender gap.
Sugumar H; Nanayakkara S; Chieng D; Wong GR; Parameswaran R; Anderson RD; Al-Kaisey A; Nalliah CJ; Azzopardi S; Prabhu S; Voskoboinik A; Lee G; McLellan AJ; Ling LH; Morton JB; Kalman JM; Kistler PM
Heart Rhythm; 2020 May; 17(5 Pt A):692-698. PubMed ID: 31866381
[TBL] [Abstract][Full Text] [Related]
34. Blanking Period Phenomenon After a Second Atrial Fibrillation Ablation Session: The Application and Factors Related to It.
Fujimoto Y; Hayashi M; Iwasaki YK; Yodogawa K; Yamamoto T; Tsuboi I; Takahashi K; Izumi Y; Oka E; Hagiwara K; Miyauchi Y; Shimizu W
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):159-166. PubMed ID: 27859851
[TBL] [Abstract][Full Text] [Related]
35. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.
Kang JH; Lee DI; Kim S; Kim MN; Park YM; Ban JE; Choi JI; Lim HE; Park SW; Kim YH
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453
[TBL] [Abstract][Full Text] [Related]
36. Long-term changes in heart rate variability after radiofrequency catheter ablation for atrial fibrillation: 1-year follow-up study with irrigation tip catheter.
Kang KW; Kim TH; Park J; Uhm JS; Joung B; Hwang C; Lee MH; Pak HN
J Cardiovasc Electrophysiol; 2014 Jul; 25(7):693-700. PubMed ID: 24575794
[TBL] [Abstract][Full Text] [Related]
37. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
[TBL] [Abstract][Full Text] [Related]
38. Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact force-sensing catheter: real-world experience from a prospective, multicentre observational cohort registry.
De Potter T; Van Herendael H; Balasubramaniam R; Wright M; Agarwal SC; Sanders P; Khaykin Y; Latcu DG; Maury P; Pani A; Hayes J; Kalman J; Nery P; Duncan E
Europace; 2018 Nov; 20(FI_3):f410-f418. PubMed ID: 29315382
[TBL] [Abstract][Full Text] [Related]
39. Early stage of left atrium remodelling predicts better outcome in long-term follow-up of atrial fibrillation ablation.
Zakrzewska-Koperska J; Derejko P; Walczak F; Urbanek P; Bodalski R; Orczykowski M; Kalińczuk L; Jedynak Z; Michałowska I; Oręziak A; Bilińska M; Przybylski A; Szumowski L
Kardiol Pol; 2014; 72(10):925-33. PubMed ID: 24846366
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of pulmonary vein isolation using a surround flow catheter with contact force measurement capabilities: A multicenter registry.
Stabile G; Di Donna P; Schillaci V; Di Monaco A; Iuliano A; Caponi D; Urraro F; Solimene F; Grimaldi M; Scaglione M
J Cardiovasc Electrophysiol; 2017 Jul; 28(7):762-767. PubMed ID: 28422368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]